| [Download PDF]
|Year : 2008 | Volume
| Issue : 3 | Page : 230-233
Herpes simplex virus 2 infection: A risk factor for HIV infection in heterosexuals
K Anuradha1, H Maan Singh2, KVT Gopal1, G Raghu Rama Rao1, TV Ramani2, Jyothi Padmaja2,
1 Department of Dermatology, Andhra Medical College, Visakhapatnam, Andhra Pradesh, India
2 Department of Microbiology, Andhra Medical College, Visakhapatnam, Andhra Pradesh, India
G Raghu Rama Rao
Consultant Dermatologist, Gopal Sadan, D.No: 15-1-2C, Naoroji Road, Maharanipeta, Visakhapatnam - 530 002, AP
Background: Genital ulcerative disease is one of the risk factors for acquisition of HIV. As HSV-2 infection is currently the most common cause of genital ulcerative disease, it acts as a potential risk factor for HIV infection. The present study was undertaken to know the seroprevalence of antibodies to HSV-2 in HIV seropositive individuals and in the general population, and to ascertain if HSV-2 is a risk factor for developing HIV infection. Methods: The study group included one hundred new HIV seropositive persons irrespective of active genital herpes or history of genital herpes. Fifty age- and sex- matched healthy volunteers were included as controls. In all patients and controls, diagnostic serology was done for HSV-2 using HSV-2-specific glycoprotein IgG2 by indirect immunoassay using the ELISA test. Statistical value «SQ»P«SQ» was calculated using the Chi-squared test. Results: Out of the 100 HIV seropositives, 66 were males and 34 were females with an age range of 20-54 years. In only 22 (19 males and 3 females) of these, positive history of genital herpes was obtained. In 49 out of the 100 HIV seropositives, IgG2 antibodies against HSV-2 were detected. In the control group, 11 out of 50 controls were seropositive for HSV-2 IgG2 antibody. There was a statistically significant association between HSV-2 and HIV seropositivity with «SQ»P«SQ» value < 0.005. Conclusion: The high prevalence of HSV-2 seropositivity in the HIV-infected group (49%) as compared to normal controls (22%) was statistically significant. Prior HSV-2 infection could be an important risk factor for acquisition of HIV in our patients.
|How to cite this article:|
Anuradha K, Singh H M, Gopal K, Rama Rao G R, Ramani T V, Padmaja J. Herpes simplex virus 2 infection: A risk factor for HIV infection in heterosexuals.Indian J Dermatol Venereol Leprol 2008;74:230-233
|How to cite this URL:|
Anuradha K, Singh H M, Gopal K, Rama Rao G R, Ramani T V, Padmaja J. Herpes simplex virus 2 infection: A risk factor for HIV infection in heterosexuals. Indian J Dermatol Venereol Leprol [serial online] 2008 [cited 2019 Aug 18 ];74:230-233
Available from: http://www.ijdvl.com/text.asp?2008/74/3/230/41367
Genital ulcerative disease is one of the risk factors for acquisition of human immunodeficiency virus (HIV) infection because of the disruption of the epithelial barrier and infiltration by CD4+ lymphocytes which are targets for HIV infection. In the recent decades, prevalence of herpes simplex infection is on the rise ,, and herpes simplex virus 2 (HSV-2) infection is currently the most common cause of genital ulcerative disease. ,, Hence, HSV-2 may act as a potential risk factor for the acquisition of HIV infection. ,,,
Till now, very few studies have been carried out in Asia to compare the seroprevalence of HSV-2 in HIV-positive individuals with that in the general population. ,,, The present study was undertaken to know the seroprevalence of HSV-2 in HIV-positive individuals and in the general population, in and around Visakhapatnam, and to ascertain if HSV-2 is a risk factor for HIV infection.
This study was conducted in the Department of Dermatology, King George Hospital, Andhra Medical College, Visakhapatnam between June and December, 2004. The study group included one hundred newly detected cases seropositive for HIV infection, both symptomatic and asymptomatic, irrespective of active genital herpes or history of genital herpes. The HIV status of all the patients was established with ELISA test done as per the NACO guidelines. Patients already on antiretroviral therapy (ART) were excluded. Fifty age- and sex- matched healthy volunteers were included as controls. In all cases, a thorough history was taken including demographic data, age of sexual debut, lifetime number of sexual partners, and past history of any sexually transmitted infection (STI). History of genital herpes and number of such attacks were recorded.
A thorough clinical examination along with all relevant investigations like complete hemogram, serum biochemistry profile, complete urine examination etc. were carried out. Venereal disease research laboratory (VDRL) test was also done in all patients and controls. CD4 and CD8 estimations and HIV viral load could not be done. Spouses of both cases and controls were not examined or tested. Five ml of blood was collected from all patients and controls, and diagnostic serology was done for HSV-2 using HSV-2-specific glycoprotein IgG2 by indirect immunoassay using ELISA (using EUROIMMUN, enzyme immunoassay kit of herpes simplex type 2 (HSV-2 IgG)). The EUROIMMUN kit ELISA test specifically detects IgG class antibodies directed against HSV-2 glycoproteinG2. Cross-reactivity with antibodies against HSV-1 leading to false positive results does not occur with ELISA. The test done with this kit, as compared to the western blot for HSV-2, is 98% specific and 100% sensitive. Statistical value 'P' was calculated using the Chi-square test to know the significance of association between HSV-2 and HIV in the case and control groups.
Out of 100 HIV cases, 66 were males and 34 were females. The age of the cases varied from 20 to 54 years, with a mean age of 32.5 years. Out of 66 males, 60 were married and 6 were unmarried. History of exposure to multiple partners was obtained from all the males. All the females except one were married. One unmarried female was a sex worker. Twenty-two cases (19 males and 3 females) gave a positive history of genital herpes. Out of these 22 cases, 3 males had active genital lesions at the time of the examination. In the control group, there were 30 males and 20 females with a mean age of 31.5 years. Only in 3 cases, positive history of genital herpes was obtained and active disease was not seen in any of these cases. In all the cases and controls, there was no evidence of any other active STI and the serum VDRL test was negative.
In the HIV seropositive group, 49 out of the 100 cases (49%) were seropositive for HSV-2 IgG antibodies, of which 30 were males and 19 were females. In the control group, 11 out of 50 controls (22%) were seropositive for HSV-2 IgG antibody and out of these, 9 were males and 2 were females [Table 1]. The prevalence of HSV-2 seropositivity was higher among HIV-seropositive females, 19 out of 34 cases (52.94%) when compared to males, 30 out of 66 cases (46.96%). The prevalence of seropositivity for HSV-2 increased with increasing age in both HIV-positive cases and controls [Table 2]. It was 34.37%, 52.27%, 61.90%, and 66.66% in 20-29, 30-39, 40-49, and >50 years age groups, respectively. The age group of 30-39 had the highest number of HSV-2 seropositives in both the cases and controls. There was a statistically significant association between HSV-2 seropositivity and HIV seropositivity (X 2 = 8.19, P , Several studies have revealed that genital herpes is currently the most common genital ulcerative disease. ,, More recently, several groups have reported that serological evidence of herpes simplex virus type 2 infection is associated with increased HIV-1 infection. ,
Asymptomatic shedders can transmit infection and thus are important epidemiologically for 70% of cases. The risk of shedding increases in individuals with recently acquired HSV-2 (within one year) and in individuals with frequent symptomatic recurrences. 
In our study, out of 50 controls, history of genital herpes was obtained only in 3 cases, though seropositivity was observed in 11 cases. Similarly, in the HIV-seropositive group, out of 100 cases, history of genital herpes was obtained in 22 and active genital lesions were seen in 3 cases, though seropositivity was observed in 49 cases. These observations reveal that serological examination is an accurate tool to know the seroprevalence of HSV-2 in the general population, particularly in asymptomatic carriers.
The present study showed that the seroprevalence of HSV-2 in the general population in our area is around 22%. This observation is almost similar to the observations of Flemming et al  and Varela et al,  who reported the seroprevalence of HSV-2 infection in the general population of the United States and Spain to be 21.9% and 25%, respectively. Some other previous studies have reported a higher seroprevalence of HSV-2. ,
In the present study of 100 HIV-positive cases, only the heterosexual mode of transmission of HSV and HIV was noted. None of the patients gave any history of homosexual exposure. Similar sexual behavior was observed in the control group, highlighting the sexual behavior pattern of the population in this region. This establishes that heterosexual mode is the main route of transmission of HSV/HIV in this area. The observation of 49% seropositivity for HSV-2 in HIV-positive individuals is in correlation with previous studies. , A very high HSV-2 seropositivity in HIV-infected individuals was observed in North America and Africa. ,
It was also observed in the present study that the seropositivity for HSV-2 in HIV cases is slightly higher in females (52.94%) than in males (46.96%). This shows that women are more vulnerable for acquisition of HSV and HIV than men. The present study also showed that the percentage of seropositivity for HSV-2 increased with increasing age of the individuals tested. The age group of 30-39 had the highest number of HIV and HSV-2 seropositives and also the highest number of HSV-2 seropositives among controls. Similar observations were made in earlier studies. , These findings reveal that this is the most vulnerable age-group for acquiring these two diseases. Statistical analysis showed that there is a statistically significant association between HSV-2 and HIV infection (X 2 = 8.19, P ,,, This once again establishes the role of HSV-2 in acquiring HIV infection.
The high seroprevalence of HSV-2 may act as one of the contributing factors for HIV acquisition among heterosexuals. Unlike patients with other genital ulcerative diseases, those who have had genital herpes are often unaware of prior infection, making serological evidence a more accurate predictor of prior genital herpes.
These asymptomatic seropositive patients, who continue to engage in unprotected sexual activities, may be responsible for increased transmission of both HSV-2 and HIV to uninfected partners. Genital herpes infections are the commonest cause of disruption of epithelial barrier and infiltration of CD4 cells locally in the genital mucosa. Thus, these infections act as a major risk factor for acquisition of HIV. Early detection, treatment, counseling, and health education of genital herpes cases would play an important role in controlling the dreaded epidemic of HIV.
|1||Smith JS, Robinson NJ. Age specific prevalence of infection with herpes simplex virus types 2 and 1: A global review. J Infect Dis 2002;186:S23-8.|
|2||Marques AR, Straus SE. Herpes simplex. In : Freedberg IM, Eisen AZ, Klaus W, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatrick's dermatology in general medicine. 6 th ed. New York: McGraw Hill; 2003. p. 2059-70.|
|3||Yeung-yue KA, Brentjens MH, Lee PC, Tyring SK. Herpes simplex viruses 1 and 2. Dermatol Clin 2002;20:249-66.|
|4||Haliona B, Malkin JE. Epidemiology of genital herpes: Recent advances. Eur J Dermatol 1999;9:177-84.|
|5||Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-11.|
|6||Kumar B, Gupta S, Sahoo BL. Epidemiology of genital herpes: Current concepts. Indian J Sex Transm Dis 2001;22:2-4.|
|7||Sayal SK, Gupta CM, Sanghi S. HIV infection in patients of sexually transmitted disease. Indian J Dermatol Venereol Leprol 1999;65:131-3.|
|8||Stamm WE, Handsfield HH, Rompalo AM, Ashley RL, Roberts PL, Corey L. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988;260:1429-33.|
|9||Severson LL, Tyring SK. Relation between herpes simplex viruses and human immunodeficiency virus infections. Arch Dermatol 1999;135:1393-7.|
|10||Hook EW 2 nd , Cannon RO, Nahmias AJ, Lee FF, Campbell CH, Glasser D. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis 1992;165:251-5.|
|11||Aggarwal A, Kaur R Seroprevalence of herpes simplex virus-1 and 2 antibodies in STD clinic patients. Indian J Med Microbiol 2004;22:244-6.|
|12||Shivaswamy KN, Thappa DM, Jaisankar TJ, Sujatha S. High seroprevalence of HSV-1 and HSV-2 in STD clinic attendees and non-high risk controls: A case control study at a referral hospital in south India. Indian J Dermatol Venereol Leprol 2005;71:26-30.|
|13||Ambhore NA, Thakar YS, Gaval SR. Seroprevalence of herpes simplex virus type-2 in STD patients with genital ulcers. Indian J Sex Transm Dis 1998;19:81-4.|
|14||Hashido M, Lee FK, Nahmias AJ, Tsugami H, Isomura S, Nagata Y, et al. An epidemiologic study of herpes simplex type 1 and 2 infection in Japan based on type specific serological assays. Epidemiol Infect 1998;120:179-86.|
|15||Chen CY, Ballard RC, Beck-Sague CM, Dangor Y, Radebe F, Schmid S, et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa: The herpetic connection. Sex Transm Dis 2000;27:21-9.|
|16||Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS 2006;20:73-83.|
|17||Mbizvo EM, Msuya Sia E, Stray-Pedersen B, Chirenje MZ, Munjoma M, Hussain A. Association of herpes simplex virus type 2 with the human immunodeficiency virus among urban women in Zimbabwe. Int J STD AIDS 2002;13:343-8.|
|18||Varela JA, Garcia-Corbeira P, Aguanell MV, Boceta R, Ballesteros J, Aguilar L, et al. Gerpes simplex virus type 2 seroepidemiology in Spain: Prevalence and seroconversion rate among sexually transmitted disease clinic attendees. Sex Transm Dis 2001;28:47-50.|
|19||Smith JS, Herrero R, Munoz N, Eluf-Neto J, Ngelangel C, Bosch FX et al. Prevalence and risk factors for herpes simlex virus type 2 infection among middle age women in Brazil and the Philippines. Sex Transm Dis 2001;28:187-94|
|20||Oberle MW, Rosero-Bixby L, Lee FK, Sanchez-Braverman M, Nahmias AJ, Guinan ME. Herpes simplex virus type 2 antibodies: High prevalence in monogamous women in Costa Rica. Ann J Trop Med Hyg 1989;41:224-9.|
|21||van Benthem BH, Spaargaren J, van Den Hoek JA, Merks J, Coutinho RA, Prins M, et al. Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sex Transm Infect 2001;77:120-4.|
|22||Bystricka M, Gasparovicova L, Stanekova D, Mokras M, Solarikova L, Russ G. Prevalence of antibodies to herpes simplex virus 2 among homosexual men either positive or negative for human immunodeficiency viruses in Slovakia. Acta Virol 2000;44:163-7.|
|23||Mbopi-Keou FX, Gresenquet G, Mayaud P, Weiss HA, Gopal R, Matta M, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: Opportunities for intervention. J Infect Dis 2000;182:1090-6.|
|24||Russell DB, Tabrizi SN, Russell JM, Garland SM. Seroprevalence of herpes simplex virus types 1 and 2 in HIV infected and uninfected homosexual men in a primary care setting. J Clin Virol 2001;22:305-13.|